I may be naive but i believe SI and BOD have executed all four products to their best. All completed phase 3 of a novel product. No other CEO would of achieved this.
I believe the FDA is playing politics here or been influenced by other parties. I think both!
The FDA has accepted two BLA, inspected manufacturing site, gave MOA/assays a tick, but they want more data. I don't want to debate about the science as Lefty, OP, DOC and others have gone through all this.
AT worst, the FDA should of given AA and RCT for Adults. Don't tell me, MSB filled the wrong form! lol!
Unfortunately, MSB need to find more funds to tick every extra box the FDA has created. It's BS mate and deep down we know it. With emotions, we the shareholders need to blame someone and it's the CEO and BOD. Like they make the final decision! it's a bitch of a game!
The positive is, they've got so much data in their disposal, it will benefit the next stem cell company, if MSB is not around. I hope MSB sticks around, they have the right people and stakeholders.
- Forums
- ASX - By Stock
- CEO Itescu needs to go
I may be naive but i believe SI and BOD have executed all four...
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10033 | 1.485 |
4 | 53700 | 1.480 |
1 | 770 | 1.475 |
3 | 62048 | 1.460 |
1 | 50000 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 21995 | 1 |
1.505 | 24000 | 1 |
1.510 | 13666 | 2 |
1.515 | 99798 | 1 |
1.520 | 27250 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |